Merck KGaA connects R&D knowledge with graphs and GenAI in its Synaptix ecosystem
Merck Group is transforming R&D knowledge management by using Neo4j to power its “Synaptix” graph ecosystem, connecting fragmented data to enable advanced analytics and agentic AI for drug repurposing and document intelligence.
Merck Group is transforming R&D knowledge management by using Neo4j to power its “Synaptix” graph ecosystem, connecting fragmented data to enable advanced analytics and agentic AI for drug repurposing and document intelligence.
Recorded at Neo4j GraphTalk Pharma & Life Sciences, July 2025.